Fosamax and Hydroxocobalamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fosamax (alendronate sodium) and Hydroxocobalamin (hydroxocobalamin). Common drug interactions include dizziness (excl vertigo) among females and dyspnoea exertional among males.

The phase IV clinical study analyzes what interactions people have when they take Fosamax and Hydroxocobalamin. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.

On Aug, 10, 2026

85 people who take Fosamax and Hydroxocobalamin together, and have interactions are studied.

Fosamax and Hydroxocobalamin drug interactions.

What are the common drug interactions of Fosamax and Hydroxocobalamin, by gender? *:

female:

Dizziness (excl vertigo)
Dyspepsia (indigestion)
Fall
Fungaemia (fungi circulate in the blood)
Gamma-glutamyltransferase increased
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Neutropenia (an abnormally low number of neutrophils)

male:

Dyspnoea exertional (breathlessness or shortness of breath)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the common drug interactions of Fosamax and Hydroxocobalamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dyspnoea exertional (breathlessness or shortness of breath)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

60+:

Coma (state of unconsciousness lasting more than six hours)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Fall
Fungaemia (fungi circulate in the blood)
Gamma-glutamyltransferase increased
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Neutropenia (an abnormally low number of neutrophils)

What are the existing conditions these people have? *

Pain: 71 people, 83.53%

* Approximation only. Some reports may have incomplete information.

Do you take Fosamax and Hydroxocobalamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously